康芝药业
(300086)
| 流通市值：20.93亿 | | | 总市值：21.62亿 |
| 流通股本：4.41亿 | | | 总股本：4.55亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 5,771,004.69 | 16,346,475.17 | 17,269,378.96 | 59,751,946.26 |
| 应收票据及应收账款 | 25,316,549.67 | 31,055,817.96 | 41,878,482.59 | 44,161,220.74 |
| 其中：应收票据 | 127,830 | 1,413,767.5 | 1,349,000 | 7,394,827.26 |
| 应收账款 | 25,188,719.67 | 29,642,050.46 | 40,529,482.59 | 36,766,393.48 |
| 预付款项 | 27,915,577.47 | 28,268,444.8 | 36,551,072.16 | 26,846,887.06 |
| 其他应收款合计 | 9,243,523.78 | 9,731,567.38 | 10,718,629.95 | 11,633,013.23 |
| 存货 | 149,704,018.22 | 168,964,949.74 | 160,328,103.04 | 160,116,913.86 |
| 其他流动资产 | 2,112,331.06 | 3,947,433.4 | 2,061,122.26 | 1,968,637.98 |
| 流动资产合计 | 220,063,004.89 | 258,314,688.45 | 268,806,788.96 | 304,478,619.13 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 4,973,239.88 | 4,973,239.88 | 4,973,239.88 | 4,973,239.88 |
| 投资性房地产 | 556,070,287.16 | 556,070,287.16 | 556,070,287.16 | 556,070,287.16 |
| 固定资产 | 657,007,003.79 | 661,393,518.62 | 672,052,042.96 | 680,021,426.41 |
| 在建工程 | 16,512,914.77 | 16,095,895.51 | 16,048,608.95 | 18,004,948.24 |
| 使用权资产 | 16,422,622.87 | 16,664,132.02 | 16,905,641.17 | 17,147,150.32 |
| 无形资产 | 57,826,981.35 | 59,802,097.12 | 61,602,601.14 | 63,710,972.73 |
| 开发支出 | 32,961,161 | 31,074,368.55 | 31,074,368.55 | 31,074,368.55 |
| 商誉 | 8,300,000 | 8,300,000 | 8,300,000 | 8,300,000 |
| 长期待摊费用 | 21,101,558.82 | 22,940,278.06 | 25,060,784.01 | 24,794,106.07 |
| 递延所得税资产 | 66,017,329.54 | 64,738,936.75 | 64,933,209.65 | 70,744,648.69 |
| 其他非流动资产 | 9,829,328.37 | 11,278,956.55 | 11,403,211.83 | 11,684,999.3 |
| 非流动资产合计 | 1,447,022,427.55 | 1,453,331,710.22 | 1,468,423,995.3 | 1,486,526,147.35 |
| 资产总计 | 1,667,085,432.44 | 1,711,646,398.67 | 1,737,230,784.26 | 1,791,004,766.48 |
| 流动负债: | | | | |
| 短期借款 | 195,441,473.94 | 174,300,000 | 153,550,332.4 | 166,045,244.17 |
| 应付票据及应付账款 | 53,333,158.46 | 65,022,222.07 | 60,782,353.76 | 52,713,437.25 |
| 应付账款 | 53,333,158.46 | 65,022,222.07 | 60,782,353.76 | 52,713,437.25 |
| 预收款项 | 35,714.29 | 114,471.38 | 1,195,850.2 | 262,797.81 |
| 合同负债 | 12,338,738.55 | 15,954,898.61 | 14,519,146.19 | 24,533,858.99 |
| 应付职工薪酬 | 7,660,744.92 | 7,371,965.18 | 7,407,049.54 | 8,589,375.15 |
| 应交税费 | 10,359,593.55 | 11,763,509.05 | 12,930,248.1 | 15,623,473.53 |
| 其他应付款合计 | 205,651,750.35 | 210,170,428.7 | 208,977,523.03 | 230,790,291.79 |
| 一年内到期的非流动负债 | 80,243,337.16 | 80,419,038.63 | 81,241,330.99 | 81,171,331.32 |
| 其他流动负债 | 1,568,090.85 | 2,052,363.41 | 1,884,045.3 | 3,762,054.38 |
| 流动负债合计 | 566,632,602.07 | 567,168,897.03 | 542,487,879.51 | 583,491,864.39 |
| 非流动负债: | | | | |
| 长期借款 | 153,575,000 | 153,575,000 | 181,820,000 | 181,820,000 |
| 租赁负债 | 18,226,365.16 | 18,036,680.41 | 17,846,995.66 | 17,657,309.09 |
| 递延收益 | 51,668,060.9 | 52,409,168.87 | 53,150,276.84 | 53,891,384.81 |
| 递延所得税负债 | 32,747,261.94 | 32,807,639.22 | 32,868,016.51 | 32,928,393.8 |
| 非流动负债合计 | 256,216,688 | 256,828,488.5 | 285,685,289.01 | 286,297,087.7 |
| 负债合计 | 822,849,290.07 | 823,997,385.53 | 828,173,168.52 | 869,788,952.09 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 455,124,411 | 455,124,411 | 455,124,411 | 455,124,411 |
| 资本公积 | 842,991,008.41 | 842,991,008.41 | 842,991,008.41 | 842,991,008.41 |
| 其他综合收益 | 66,026,109.98 | 66,035,783.48 | 66,049,440.12 | 66,068,602.22 |
| 盈余公积 | 54,941,795.33 | 54,941,795.33 | 54,941,795.33 | 54,941,795.33 |
| 未分配利润 | -595,207,525.46 | -552,182,818.47 | -531,166,074.8 | -519,416,329.73 |
| 归属于母公司股东权益合计 | 823,875,799.26 | 866,910,179.75 | 887,940,580.06 | 899,709,487.23 |
| 少数股东权益 | 20,360,343.11 | 20,738,833.39 | 21,117,035.68 | 21,506,327.16 |
| 股东权益合计 | 844,236,142.37 | 887,649,013.14 | 909,057,615.74 | 921,215,814.39 |
| 负债和股东权益合计 | 1,667,085,432.44 | 1,711,646,398.67 | 1,737,230,784.26 | 1,791,004,766.48 |
| 公告日期 | 2026-10-26 | 2026-08-27 | 2026-04-29 | 2026-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |